Accueil   Diary - News   All news Osivax appoints Prof. Jeffrey Almond as Chairman of its Scientific Advisory Board

Osivax appoints Prof. Jeffrey Almond as Chairman of its Scientific Advisory Board

Résultat de recherche d'images pour "osivax"

 

Prof. Almond’s appointment will strengthen Osivax’s capacities to drive, position and prioritize pipeline development and especially OVX836, a broad-spectrum influenza vaccine

 

Osivax, a biopharmaceutical company currently focused on the development of a breakthrough influenza vaccine, announced today that the Company is strengthening its management team with the appointment of Prof. Jeffrey Almond as the Chairman of the Scientific Advisory Board.




Read the press release

By continuing your navigation on our site, you accept the use of cookies and the collection of your data and personal information by Lyonbiopôle, for the purposes of measuring the traffic on the website, to provide statistics and to offer you adapted content to your centers of interest. To exercise your rights of access, rectification, opposition, deletion and portability, in accordance with the General Data Protection Regulation (EU 2016/679), you are informed that you can send your request to dpo@lyonbiopole.com. More details are available by clicking here I agree